CLINICAL RESEARCH: HEART RHYTHM DISORDER
Management and Outcome of Permanent Pacemaker and Implantable Cardioverter-Defibrillator Infections
Muhammad R. Sohail, MD*,*,1,
Daniel Z. Uslan, MD*,3,
Akbar H. Khan, MD ,2,
Paul A. Friedman, MD ,
David L. Hayes, MD,
Walter R. Wilson, MD*,
James M. Steckelberg, MD*,
Sarah Stoner, MS and
Larry M. Baddour, MD*
* Division of Infectious Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota.
Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota.
Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota.
Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota.
Manuscript received October 2, 2006;
revised manuscript received December 11, 2006,
accepted January 2, 2007.
* Reprint requests and correspondence: Dr. Muhammad R. Sohail, Department of Medicine, Division of Infectious Diseases, Tawam Hospital/Johns Hopkins Medicine, P.O. Box 15258, Al Ain, Abu Dhabi, United Arab Emirates. (Email: msohail{at}tawam-hosp.gov.ae).
Data presented in part at the 43rd Annual Meeting of the Infectious Diseases Society of America, October 6 to 9, 2005, San Francisco, California (abstract no. 387).
Objectives: We describe the management and outcome of permanent pacemaker (PPM) and implantable cardioverter-defibrillator (ICD) infections in a large cohort of patients seen at a tertiary care facility with expertise in device lead extraction.
Background: Infection is a serious complication of PPM and ICD implantation. Optimal care of patients with these cardiac device infections (CDI) is not well defined.
Methods: A retrospective review of all patients with CDI admitted to Mayo Clinic Rochester between January 1, 1991, and December 31, 2003, was conducted. Demographic and clinical data were collected, and descriptive analysis was performed.
Results: A total of 189 patients met the criteria for CDI (138 PPM, 51 ICD). The median age of the patients was 71.2 years. Generator pocket infection (69%) and device-related endocarditis (23%) were the most common clinical presentations. Coagulase-negative staphylococci and Staphylococcus aureus, in 42% and 29% of cases, respectively, were the leading pathogens for CDI. Most patients (98%) underwent complete device removal. Duration of antibiotic therapy after device removal was based on clinical presentation and causative organism (median duration of 18 days for pocket infection vs. 28 days for endocarditis; 28 days for S. aureus infection vs. 14 days for coagulase-negative staphylococci infection [p < 0.001]). Median follow-up after hospital discharge was 175 days. Ninety-six percent of patients were cured with both complete device removal and antibiotic administration.
Conclusions: Cure of CDI is achievable in the large majority of patients treated with an aggressive approach of combined antimicrobial treatment and complete device removal. Based on findings of our large retrospective institutional survey and previously published data, we submit proposed management guidelines of CDI.
|
Abbreviations and Acronyms
| | BSI = blood stream infection | | CDI = cardiac device infection | | CoNS = coagulase-negative staphylococci | | ICD = implantable cardioverter-defibrillator | | PPM = permanent pacemaker |
|
This article has been cited by other articles:
|
|
|
|
 
F. Franceschi, F. Thuny, R. Giorgi, I. Sanaa, E. Peyrouse, X. Assouan, S. Prevot, E. Bastard, G. Habib, and J.-C. Deharo
Incidence, risk factors, and outcome of traumatic tricuspid regurgitation after percutaneous ventricular lead removal.
J. Am. Coll. Cardiol.,
June 9, 2009;
53(23):
2168 - 2174.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.J. P. Raatikainen, J. Perala, and J. Lahtinen
Successful defibrillator lead remnant extraction from right ventricle using a steerable transseptal sheath and a basket retriever
Europace,
May 29, 2009;
(2009)
eup133v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J C Lekkerkerker, C van Nieuwkoop, S A Trines, J G van der Bom, A Bernards, E T van de Velde, M Bootsma, K Zeppenfeld, J W Jukema, J-W Borleffs, et al.
Risk factors and time delay associated with cardiac device infections: Leiden device registry
Heart,
May 1, 2009;
95(9):
715 - 720.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Schulz, K. Puschel, and E. E. Turk
Fatal complications of pacemaker and implantable cardioverter-defibrillator implantation: medical malpractice?
Interactive CardioVascular and Thoracic Surgery,
April 1, 2009;
8(4):
444 - 448.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. S. Baman, S. K. Gupta, J. A. Valle, and E. Yamada
Risk Factors for Mortality in Patients With Cardiac Device-Related Infection
Circ Arrhythmia Electrophysiol,
April 1, 2009;
2(2):
129 - 134.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Bis, K. Goscinska-Bis, M. Krejca, E. Zinka, J. Skarysz, L. Machej, and A. Bochenek
Surgical extraction of cardiac resynchronization therapy system with concomitant implantation of a new system with the use of epicardial leads in a patient with endocarditis
J. Thorac. Cardiovasc. Surg.,
September 1, 2008;
136(3):
786 - 787.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Pichlmaier, V. Marwitz, C. Kuhn, M. Niehaus, G. Klein, C. Bara, A. Haverich, and W.-R. Abraham
High prevalence of asymptomatic bacterial colonization of rhythm management devices
Europace,
September 1, 2008;
10(9):
1067 - 1072.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. R. Sohail, D. Z. Uslan, A. H. Khan, P. A. Friedman, D. L. Hayes, W. R. Wilson, J. M. Steckelberg, S. M. Jenkins, and L. M. Baddour
Infective Endocarditis Complicating Permanent Pacemaker and Implantable Cardioverter-Defibrillator Infection
Mayo Clin. Proc.,
January 1, 2008;
83(1):
46 - 53.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
